Federal Register / Vol. 79, No. 233 / Thursday, December 4, 2014 / Notices 72003 

Staff (MOS), coordinates the activities of 

the ACF Native American Affairs 

Liaison Workgroup, serves as the ANA 

liaison to the Inter-Departmental 

Council on Native American Affairs, 

provides coordination of ANA’s data 

driven strategic plan, and advises the 

Commissioner on strategic and 

operational activities of ANA. 

The MOS provides administrative and 

budget support to ANA. These 

responsibilities include: (1) Serving as 

the Executive Secretariat for ANA, 

including managing correspondence, 

correspondence systems, and public 

requests including, but not limited to 

Freedom of Information Act (FOIA) 

requests; (2) coordinating human 

resources activities; (3) developing and 

executing the budget; (4) providing ongoing administrative technical support 

of ANA contracts; and (5) as 

appropriate, developing internal 

policies and procedures relating to these 

activities. 

B. The Division of Program 

Operations is primarily responsible for 

the pre-award and post-award 

administration of discretionary grant 

programs to eligible Tribes and nonprofit Native American organizations. 

These responsibilities include: (1) 

Developing ANA’s Funding 

Opportunity Announcements; (2) 

managing annual grant competitions, 

including coordination of the panel 

review process and internal application 

review; (3) on-going grantee monitoring 

and support; (4) administering grant 

award portfolio, including close-out; 

and (5) providing liaison to the Office of 

Administration, Divisions of Grants 

Management and Division of Grants 

Policy. 

C. The Division of Program Evaluation 

and Planning is responsible for 

evaluations of grantee effectiveness and 

impact as well as ANA performance 

including, but not limited to 

Government Performance and Results 

Act measures. These responsibilities 

include: (1) Oversight of planning and 

implementation activities related to 

ANA program evaluation, including 

development of annual reports, which 

includes the annual Report to Congress 

on Impact and Effectiveness; (2) data 

analyses and special organizational 

studies to guide programmatic 

enhancements and inform training and 

technical assistance efforts; (3) 

coordination of pre-award and postaward training and technical assistance 

activities in Alaska, the Pacific Basin, 

and the lower forty-eight states; (4) 

coordination of ANA’s data and social 

media tools; and (5) liaison with the 

Office of Planning, Research and 

Evaluation. 

D. The Division of Policy is 

responsible for providing support and 

guidance to define, establish, and 

disseminate policy affecting Native 

American communities at large. These 

responsibilities include: (1) 

Management of a unified and effective 

policy formulation process, including 

coordination of ANA regulations and 

other policy issuances affecting grantees 

and Native American communities; (2) 

formulation of advice on tribal and state 

legislative, and other activities affecting 

Native Americans; (3) development of 

long- and short-term strategies to 

address issues raised in consultations 

and collaborations with Native 

Americans; (4) support of the activities 

of the ACF Tribal Advisory Committee 

and other committees, councils, and 

workgroups affecting Native Americans; 

and (5) liaison with the Office of the 

General Counsel and others in the 

Department on matters involving or 

affecting Native Americans. 

II. Continuation of Policy. Except as 

inconsistent with this reorganization, all 

statements of policy and interpretations 

with respect to organizational 

components affected by this notice 

within ACF, heretofore issued and in 

effect on this date of this reorganization 

are continued in full force and effect. 

III. Delegation of Authority. All 

delegations and redelegations of 

authority made to officials and 

employees of affected organizational 

components will continue in them or 

their successors pending further 

redelegations, provided they are 

consistent with this reorganization. 

IV. Funds, Personnel, and Equipment. 

Transfer of organizations and functions 

affected by this reorganization shall be 

accompanied in each instance by direct 

and support funds, positions, personnel, 

records, equipment, supplies, and other 

resources. 

This reorganization will be effective 

upon date of signature. 

Dated: November 24, 2014. 

Mark H. Greenberg, 

Acting Assistant Secretary for Children and 

Families. 

[FR Doc. 2014–28486 Filed 12–3–14; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; 60-Day Comment 

Request; Health Information National 

Trends Survey (HINTS) 

Summary: In compliance with the 

requirement of Section 3506(c)(2)(A) of 

the Paperwork Reduction Act of 1995, 

for opportunity for public comment on 

proposed data collection projects, the 

National Cancer Institute (NCI), 

National Institutes of Health (NIH), will 

publish periodic summaries of proposed 

projects to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

Written comments and/or suggestions 

from the public and affected agencies 

are invited on one or more of the 

following points: (1) Whether the 

proposed collection of information is 

necessary for the proper performance of 

the function of the agency, including 

whether the information will have 

practical utility; (2) The accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

Ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Ways to minimize the 

burden of the collection of information 

on those who are to respond, including 

the use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology. 

To Submit Comments and For Further 

Information: To obtain a copy of the 

data collection plans and instruments, 

submit comments in writing, or request 

more information on the proposed 

project contact: Bradford W. Hesse, 

Ph.D., Health Communication and 

Informatics Research Branch, 9609 

Medical Center Drive, MSC 9761, Room 

3E610, Rockville, MD 20850 or call nontoll free number 240–276–6721 or Email 

your request, including your address, to 

hesseb@mail.nih.gov. Formal requests 

for additional plans and instruments 

must be requested in writing. 

Comment Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 60 days of the date of 

this publication. 

Proposed Collection: Health 

Information National Trends Survey 

(HINTS) 0925–0538, Reinstatement with 

Change, National Cancer Institute (NCI), 

National Institutes of Health (NIH). 

Need and Use of Information 

Collection: This partnership between 

NCI and FDA will include assessing the 

public’s knowledge of medical devices, 

communications related to product 

recalls, nutritional supplement labeling, 

and topics to inform FDA’s regulatory 

authority over tobacco, such as risk 

perceptions about new tobacco 

products, product pack color gradations, 

perceptions of product harm, and 

tobacco product claims and labels. This 

HINTS survey will couple knowledgemstockstill on DSK4VPTVN1PROD with NOTICES

72004 Federal Register / Vol. 79, No. 233 / Thursday, December 4, 2014 / Notices 

related questions with inquiries into the 

communication channels through which 

understanding is being obtained, and 

assessment of FDA-regulated material. 

This survey will extend the information 

collected and priorities from HINTS 

which have been to provide a 

comprehensive assessment of the 

American public’s current access to, and 

use of, information about cancer across 

the cancer care continuum from cancer 

prevention, early detection, diagnosis, 

treatment, and survivorship. 

OMB approval is requested for 1 year. 

There are no costs to respondents other 

than their time. The total estimated 

annualized burden hours are 2,159. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total annual 

burden hour 

Individuals ........................................................................................................ 4,318 1 30/60 2,159 

Dated: November 24, 2014. 

Karla Bailey, 

NCI Project Clearance Liaison, National 

Institutes of Health. 

[FR Doc. 2014–28513 Filed 12–3–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; 60-Day Comment 

Request; Surveys and Interviews To 

Support an Evaluation of the 

Innovative Molecular Analysis 

Technologies (IMAT) Program (NCI) 

SUMMARY: In compliance with the 

requirement of Section 3506(c)(2)(A) of 

the Paperwork Reduction Act of 1995, 

for opportunity for public comment on 

proposed data collection projects, the 

National Cancer Institute (NCI), 

National Institutes of Health (NIH), will 

publish periodic summaries of proposed 

projects to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

Written comments and/or suggestions 

from the public and affected agencies 

are invited on one or more of the 

following points: (1) Whether the 

proposed collection of information is 

necessary for the proper performance of 

the function of the agency, including 

whether the information will have 

practical utility; (2) The accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

Ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Ways to minimize the 

burden of the collection of information 

on those who are to respond, including 

the use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology. 

To Submit Comments and For Further 

Information: To obtain a copy of the 

data collection plans and instruments, 

submit comments in writing, or request 

more information on the proposed 

project, contact: Anthony Dickherber, 

NCI Center for Strategic Scientific 

Initiatives, 31 Center Drive, Rm10A33, 

Bethesda, MD 20892 or call non-toll-free 

number 301–547–9980 or Email your 

request, including your address to: 

dickherberaj@mail.nih.gov. Formal 

requests for additional plans and 

instruments must be requested in 

writing. 

Comment Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 60 days of the date of 

this publication. 

Proposed Collection: Surveys and 

Interviews to Support an Evaluation of 

the Innovative Molecular Analysis 

Technologies (IMAT) Program (NCI), 

0925–NEW, National Cancer Institute 

(NCI), National Institutes of Health 

(NIH). 

Need and Use of Information 

Collection: The purpose of the proposed 

evaluation is to pursue a comprehensive 

process and outcome assessment of the 

15-year old Innovative Molecular 

Analysis Technologies (IMAT) program. 

While the program consistently offers 

promising indicators of success, the full 

program has not been evaluated since 

2008, and never in as comprehensive a 

manner as has been formulated in the 

current evaluation plan. An outcome 

evaluation of the long-standing National 

Cancer Institute’s (NCI) IMAT program 

presents a rich and unique opportunity 

likely to serve institutes across the 

National Institutes of Health (NIH), and 

perhaps other federal agencies, 

considering the costs and benefits of 

directing resources towards supporting 

technology development. An award 

through the NIH Evaluation Set-Aside 

program to support this evaluation, for 

which NIH-wide relevance is a principle 

element of determining merit for 

support, is testament to this. The 

evaluation serves as an opportunity to 

gauge the impact of investments in 

technology development and also to 

assess the strengths and weaknesses of 

phased innovation award mechanisms. 

Like all institutes and centers (ICs) of 

the NIH, NCI seeks opportunities for 

improving their programs’ utility for the 

broad continuum of researchers, 

clinicians and ultimately patients. NCI 

Director Harold Varmus and other 

leadership across NCI, as well as the 

NCI Board of Scientific Advisors, will 

be the primary users of the evaluation 

results. Findings are primarily intended 

for considering the long-term strategy to 

support innovative technology 

development and how to more 

efficiently translate emerging 

capabilities through such technologies 

into the promised benefits for cancer 

research and clinical care. Interviews 

with grantees, program officers, review 

officers, and other NIH awardees make 

up a crucial component of the 

evaluation plan and will largely follow 

set survey protocols. Specific near-term 

aims include the use of this information 

to consider the utility of continued 

investment through existing 

solicitations and in strategic planning 

generally for institute support for 

innovative technology development. 

OMB approval is requested for 1 year. 

There are no costs to respondents other 

than their time. The total estimated 

annualized burden hours are 575. 

mstockstill on DSK4VPTVN1PROD with NOTICES